Abstract
Somatostatin-like immunoreactivity is reduced in the cerebrospinal fluid in depression and this is presumed to reflect alterations in cerebral somatostatinergic systems. We have examined this hypothesis by measuring this immunoreactivity and somatostatin receptors in post-mortem cortical tissue from depressed patients and control subjects. There was no significant difference in the temporal and occipital cortex in somatostatin-like immunoreactivity or in somatostatin receptor affinity and binding capacity between depressed and control groups. It is concluded that there may not be an alteration of cortical somatostatin function in depression.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Beal M. F., Mazurek M. F., Tran V. T., Chattha G., Bird E. D., Martin J. B. Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease. Science. 1985 Jul 19;229(4710):289–291. doi: 10.1126/science.2861661. [DOI] [PubMed] [Google Scholar]
- Bissette G., Widerlöv E., Walléus H., Karlsson I., Eklund K., Forsman A., Nemeroff C. B. Alterations in cerebrospinal fluid concentrations of somatostatinlike immunoreactivity in neuropsychiatric disorders. Arch Gen Psychiatry. 1986 Dec;43(12):1148–1151. doi: 10.1001/archpsyc.1986.01800120034008. [DOI] [PubMed] [Google Scholar]
- Blessed G., Tomlinson B. E., Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968 Jul;114(512):797–811. doi: 10.1192/bjp.114.512.797. [DOI] [PubMed] [Google Scholar]
- Bloom S. R., Polak J. M. Somatostatin. Br Med J (Clin Res Ed) 1987 Aug 1;295(6593):288–290. doi: 10.1136/bmj.295.6593.288. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
- Candy J. M., Gascoigne A. D., Biggins J. A., Smith A. I., Perry R. H., Perry E. K., McDermott J. R., Edwardson J. A. Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease. J Neurol Sci. 1985 Dec;71(2-3):315–323. doi: 10.1016/0022-510x(85)90070-x. [DOI] [PubMed] [Google Scholar]
- Davies P., Katzman R., Terry R. D. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa. Nature. 1980 Nov 20;288(5788):279–280. doi: 10.1038/288279a0. [DOI] [PubMed] [Google Scholar]
- Doran A. R., Rubinow D. R., Roy A., Pickar D. CSF somatostatin and abnormal response to dexamethasone administration in schizophrenic and depressed patients. Arch Gen Psychiatry. 1986 Apr;43(4):365–369. doi: 10.1001/archpsyc.1986.01800040075011. [DOI] [PubMed] [Google Scholar]
- Gerner R. H., Yamada T. Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients. Brain Res. 1982 Apr 22;238(1):298–302. doi: 10.1016/0006-8993(82)90801-0. [DOI] [PubMed] [Google Scholar]
- McKeith I. G., Marshall E. F., Ferrier I. N., Armstrong M. M., Kennedy W. N., Perry R. H., Perry E. K., Eccleston D. 5-HT receptor binding in post-mortem brain from patients with affective disorder. J Affect Disord. 1987 Jul-Aug;13(1):67–74. doi: 10.1016/0165-0327(87)90075-9. [DOI] [PubMed] [Google Scholar]
- Rubinow D. R., Gold P. W., Post R. M., Ballenger J. C., Cowdry R., Bollinger J., Reichlin S. CSF somatostatin in affective illness. Arch Gen Psychiatry. 1983 Apr;40(4):409–412. doi: 10.1001/archpsyc.1983.01790040063009. [DOI] [PubMed] [Google Scholar]
- Whitford C. A., Bloxham C. A., Snell C. R., Candy J. M., Hirst B. H. Regional distribution of high-affinity [3H]somatostatin binding sites in the human brain. Brain Res. 1986 Nov 19;398(1):141–147. doi: 10.1016/0006-8993(86)91259-x. [DOI] [PubMed] [Google Scholar]